Small-plot field trials begin for soybean disease-resistance trait.

In June 2024, Upstream Biotechnology initiated small-plot field trials for its soybean disease-resistance trait, marking an important milestone in the development of its SwitchBlade crop-resilience platform. These trials are designed to evaluate trait performance under real-world growing conditions and generate critical data to support future product development.

Field testing allows Upstream to assess how effectively the technology helps soybean plants deploy their natural defense systems against disease while maintaining strong agronomic performance. By monitoring plant health, resistance levels, and yield outcomes, the company can further optimize trait performance and validate greenhouse results at a larger scale.

This milestone represents a significant step toward delivering durable solutions that help growers protect crops from increasing disease pressure. As changing environmental conditions continue to affect agriculture, Upstream's goal is to provide reliable tools that improve resilience, safeguard yields, and support long-term food security.